8-K current report · filed Nov 2, 2026

Chemours Co (CC) 8-K Current Report: November 2, 2026

Item 2.02Item EX-99.1CC overview

Short answer

Chemours Co (CC) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 financial results announced, making the filing relevant to earnings expectations and valuation.

Chemours Co 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Third-quarter 2026 financial results announced, making the filing relevant to earnings expectations and valuation
  • Detailed results available in Exhibit 99.1, including the company’s press release
  • Investor presentation scheduled for November 3, 2026, ahead of the earnings conference call

Item EX-99.1 · Exhibit EX-99.1

  • Q3 sales $1.54B, up 3%; Adjusted EBITDA $200M, up 6%, showing pricing and mix offsetting volume pressure
  • GAAP net income $196M versus $46M, aided by $150M PFAS insurance proceeds, making adjusted earnings more representative of operations
  • TSS weakness: sales down 9% and EBITDA down 30% to $136M, with margin falling to 27% on lower Opteon aftermarket demand
  • TT and APM momentum: EBITDA up 240% to $85M and 71% to $24M, respectively, driven by pricing and data-center semiconductor demand
  • Leverage remains elevated at 4.3x, while Q4 EBITDA guidance of $160M-$185M implies seasonal earnings pressure; full-year target is $775M-$800M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Chemours Co 8-K filings

Get the next CC 8-K as it lands

Follow CC for push alerts, or ask the research agent what this filing means.